Академический Документы
Профессиональный Документы
Культура Документы
Integrative Review
Jaime Beane
Nur 4122
“I pledge”
INTEGRATIVE REVIEW 2
Abstract
The purpose of this integrated review is to examine research literature that evaluates the use of
elderberry extract (a.k.a. Sambucus Nigra or S.nigra) and how it reduces the risk of respiratory
complications. Prior research has shown that the anti-microbial properties of S.nigra renders it
effective in disabling influenza viruses. The PICO question under consideration is: For patient’s
presenting with viral flu symptoms, does the use of S.nigra-based syrup reduce the risk of
integrative review. Databases such as EBSCO CINAHL Complete and Academic Search
Complete and PubMed were utilized to locate research articles. The results yielded 634 articles
total and five met the inclusion criteria. All five articles indicated that S.nigra has the capacity to
reduce respiratory complications. Limitations to the review include lack of experience by the
researcher, limited time to complete assignment, and limited number of articles for
review. Implications of this review include looking at the antimicrobial properties of the S.nigra
plant determining its method of anti-viral activity, looking at symptomology of its use during
peak illness, and applying knowledge to practice. Recommendations for future research surround
aggressiveness, improve outcomes by boosting immune response, and determining its place
Integrative Review
The purpose of this integrated review is to examine research literature that evaluates the
use of S.nigra and how it reduces the risk of respiratory complications. Prior research has shown
viruses (Shahsavandi, Ebrahimi, & Farahani, 2017). Elderberries have been used in tradition as
an herbal remedy to assist in combating the symptoms associated with the common cold and
flu (Tiralongo, Wee, & Lea, 2016). In recent years, researchers have gone beyond the traditional
use, and have begun to examine the antimicrobial properties of the Elderberry plant to determine
their key role in fighting against pathogens. There are numerous theories for why the elderberry
is so potent. One study looked at the antimicrobial properties (AMPs) of cysteine-rich peptides
found in the elderberry flower (Alvarez, Barriga, Albericio, Romero, & Guzman, 2018). Another
study looked at an extract obtained from the elderberry fruit and its cytotoxic effect on the
infectious bronchitis virus (IBV) (Chen et al., 2014). Another research study looked at the
elderberry’s method of action (MOA) in rendering the H9N2 virus ineffective through lipid raft
association (Shahsavandi et al., 2017). The last two studies looked at the symptomology effects
of taking elderberry syrup in children with otitis media with effusion (OME) (Volpe et al.,
2019) and elderberry supplementation in air-travelers with cold and flu symptoms (Tiralongo et
al., 2016). Three of these studies demonstrated the exacts obtained from the elderberry plant
destroyed viral membrane integrity, hindering the viral replication process. The other two
research studies showed positive outcomes to the respiratory tract when taking certain dosages of
elderberry extract for certain periods of time. The aim of this review is to examine and discuss
research information as it relates to the researchers PICO question: For patient’s presenting with
INTEGRATIVE REVIEW 4
viral flu symptoms, does the use of S.nigra based syrup reduce the risk of respiratory
The research design is an integrative review. The search for research articles was
conducted utilizing the computer-based search engines EBSCO CINAHL Complete and
Academic Search Complete, and PubMed. The search terms included, ‘Elderberry’, ‘Sambucus
Nigra’, ‘antimicrobial properties’, and ‘cold and flu symptoms.’ The results initially yielded
558 articles from EBSCO CINAHL Academic Search Complete, and 76 articles from PubMed.
To maintain a current approach to the issue, the search was limited to peer-reviewed qualitative
and quantitative nursing research journal articles, published in English, and written between
2014-2019. That articles had to pertain to the researcher’s PICO question: For patients
presenting with viral flu symptoms, does the use of S.nigra based syrup reduce the risk of
respiratory complications compared with no alternative treatment. The articles were then
selected based on the following inclusion criteria: Elderberry, Sambucus nigra, cold and flu
symptoms, and antimicrobial properties. The research articles were screened based on inclusion
criteria and PICO question significance. Articles that did not meet criteria were excluded from
the review. The screening produced five school-based intervention quantitative articles that are
The findings and results of the five reviewed studies indicate that S.Nigra is beneficial in
combatting viral cold and flu symptoms and improving the immune response in individuals
taking this supplement (Alvarez et al., 2018; Chen et al., 2014; Shahsavandi et al., 2017;
Tiralongo et al., 2016; and Volpe et al., 2019). A summary of these articles are attached via
INTEGRATIVE REVIEW 5
Appendix 1. This review is structured based on the following themes found among the use of
S.Nigra-based extract: Cytotoxicity and method of action and benefits in respiratory illness.
Three of the five referenced articles, the researchers investigated the anti-microbial
properties of S. Nigra (Alvarez et al., 2018; Chen et al., 2014; & Shahsavandi et al., 2017).
Researchers Alvarez et al. (2018) investigated peptide extracts retrieved from the elderberry
flower. What prompted this investigation was prior studies that have investigated substituting
chemical preservatives and insecticides with antimicrobial peptides in agriculture because of its
antimicrobial properties (Alvarez et al., 2018). Alvarez and his fellow researchers decided to
create their own peptide extracts from the elderberry flower and see how the extract affected the
Ordalii (Alvarez et al., 2018). Through scanning electron microscopy, the researchers
discovered that the extract killed the bacteria through a carpet mechanism that involved cellular
Chen and his fellow researchers (2014) looked at how S.nigra extract from its fruit
affected the infectious bronchitis virus (IBV), a pathogenic coronavirus. The ineffectiveness of
the IBV vaccination is what prompted these researchers to investigate further. These researchers
actually tested three different extracts, and only the S.nigra extract was found to have inhibited
viral replication (Chen et al., 2014). Chen and his fellow researchers (2014) also concluded that
the S.Nigra disrupted the cellular membrane of the virus, preventing it from replicating.
Shahsavandi and his fellow researchers (2017) looked into the lipid raft association
mechanism of the S.nigra extract and how it prevents the replication of the influenza virus. Lipid
raft association is the term used for when a virus membrane fuses with a cell and allows it to
INTEGRATIVE REVIEW 6
budd and replicate. Shahsavandi and his fellow researchers (2017) studied this mechanism of
action of the S.nigra fruit in human epithelial cells that were infected with the H9N2 influenza
virus through scanning electron microscopy. Five different concentrations of the S.nigra extract
were examined. The conclusion of their study showed that higher dosages of S.Nigra targeted
the viral entry process through cellular membrane destruction (Shahsavandi et al., 2017).
Three groups of researchers looked at the properties of extracts from the S.nigra plant (2
from the fruit and 1 from the flower), at different time periods through different methods, and all
came to the conclusion the S.nigra extract destroys the cellular membrane of the virus or bacteria
being studied. Of the pathogens studied were four-gram negative bacteria strains, and two
influenza strains, the infectious bronchitis virus (a form of coronavirus) and the avian flu
(H9N2). The S.nigra extract effectively destroyed the membranes of each of these pathogens,
Tiralongo and his research fellows (2016) and Volpe and his research fellows (2019)
investigated the symptomology effects of taking S.Nigra in air travellers presenting with cold
and flu symptoms (Tiralongo et al., 2016) and in children with otitis media with effusion (Volpe
et al., 2019). Tiralongo and his fellows studied a group of 312 economy class passengers
placebo-controlled clinical trial. Participants were randomly assigned trial capsules and cold
episodes, its duration, and symptoms were recorded daily. Results demonstrated that the placebo
group had cold durations of up to 117 days and those in the S.Nigra group had cold durations
averaging 57 days. The final determination was that S.Nigra supplementation was found to
reduce symptoms load and shorten cold duration by approximately 2 days and that the use of
INTEGRATIVE REVIEW 7
elderberry can stabilize physical health during air travel, however further research is necessary
Volpe and his fellow researchers (2019) looked at the use of a combination supplement
that included S.nigra, zinc, probiotics, and vitamins D, E, and C, in children with otitis media
with effusion (Volpe et al., 2019). This randomized clinical trial tested the outcomes through
otoscopy, tympanometry, fibro-endoscopy, and pure tone audiometry (Volpe et al., 2019). The
sample size included 198 children that were divided into four groups each receiving a specific
concentration of the supplement over a specific amount of time (Volpe et al., 2019). The fourth
group was a control group that understand just standard treatment for otitis media with effusion
(Volpe et al., 2019). Data was collected before treatment (T0), 45 days after treatment (T1) and
90 days after treatment (T2). The results demonstrated that children treated with these
supplements had better outcomes than the control group. All of the patients treated with the
supplement presented with good outcomes at T2 in all of the four outcomes measured. Group 3
that was treated with the highest concentration of the supplement had the best outcome. The
researchers determined that the supplementation helped to reduce the aggressiveness of the virus,
it helped to improve the child’s immune response, and it helped the child to recover better.
The articles selected for this review provide insight into the positives effects of taking an
S.nigra supplement in combatting viral or bacterial-related cold and flu symptoms. The PICO
question: For patient’s presenting with viral flu symptoms, does the use of S.nigra-based syrup
reduce the risk of respiratory complications compared with no alternative treatment was
supported by these five-research articles. The research study by Alvarez and his fellow
associates (2018) showed that the cysteine-rich peptides in the flowers of the elderberry plant
INTEGRATIVE REVIEW 8
exhibited antimicrobial activity against gram-negative pathogens through disrupting the cellular
membrane. Chen and his associates (2014) argued that the IBV vaccination has not been wholly
effective, so an alternative and prevention strategy is necessary to prevent the IBV infection from
becoming pandemic. They determined in their research that the polyphenols within the S.nigra
plant are responsible for disrupting the viral membrane, and that the two flavanols in S.nigra
bind to the virus and inhibit it from replicating (Chen et al., 2014). Shasavandi and his associates
(2017) expressed concern about an avian flu pandemic and the importance of having new
influenza therapies that inhibit viral entry, block viral replication, and inhibit viral growth. The
purpose of their study was to look at the lipid rafts of the virus and how the S.nigra affected it
during this stage. Their goal was to show a correlation between anti-viral therapy and lipid raft
association. Their study demonstrated that higher dosages of S.nigra extract targeted the viral
entry process and targeted the viral membrane (Shasavandi et al., 2017). The study done by
Volpe and his associates (2019) actually showed a reduction in adenoid tissue through fibro-
considering many physicians would opt for surgery to remove the adenoids, with little response
to standardized treatment over this time frame. The randomized control trial done by Tiralongo
and his associates (2016) may not seem significant in that it concluded a two day reduction in
symptoms, the difference of the symptoms experienced between these two groups were
significant with the placebo group being rated at 583 and the Elderberry group rated at 247 and
the duration of the placebo group was 117 days and those of the elderberry were 57 days
(Tiralongo et al., 2016). These findings support the idea that S.nigra-based extract supports the
immune response in treating viral cold and flu symptoms. The implications are significant in
that this researcher has sufficient evidence that supplementation with this syrup is beneficial in
INTEGRATIVE REVIEW 9
assisting to fight off viruses and thus reducing the severity and length of the respiratory
symptoms.
Limitations
All research has its limitations and should be noted as part of this integrative
this is not an exhaustive review given that only five articles were used for this class
assignment. The articles in this review were written within the past five years and cannot be
generalized due to the limited time frame of the analysis. The articles used were only
The study done by Volpe and his associates (2019) was done in a small region consisting
of 198 children. While evidence suggests that the use of supplementation assisted in the
recovery process, further research needs to be done to determine the generalizability of these
findings. The researcher recommends a similar approach be done in a much larger clinical trial
to determine the validity of the research. The randomized trial done with air travellers
(Tiralongo et al., 2016), yielded only 29 participants that actually suffered a cold out of 312
study participants, and only 12 were placed on elderberry. This is a very small study. This
generalizability, and validity. The experiments done by the other researchers have profound
results that could change antiviral therapy. This researcher recommends repeating experiments
Conclusion
The findings in this review demonstrate a correlation between S.nigra and its
researchers and their fellows found that extracts from the elderberry flower and berry
compromised viral membrane integrity. Destroying membrane integrity prevents the virus from
replicating and causing further damage. This mimics many present day antibiotics and antivirals.
The viruses that were examined were the H9N2 avian flu, the infectious bronchitis virus (IBV),
and four strains of gram negative bacteria. The significance of these findings are huge in that it
provides a baseline for studying more pathogens that affect the human population. This
researcher suggests that further experimental studies need to be done to determine the
cytotoxicity of S.nigra extract on gram positive and negative pathogens, along with other potent
Two of the other articles reflect on the positive correlation in S.nigra based extract
reducing inflammation in the tissues of the respiratory tract, such as reducing the size of adenoid
tissue, improving the outcomes of children with chronic otitis media with effusion and reducing
cold symptoms during traveling on long flights. The research studies showed a significant
improvement in upper respiratory outcomes when the participants supplemented with S.nigra
based syrup.
The articles chosen and the findings do relate to the PICO question: For patient’s
presenting with viral flu symptoms, does the use of S.nigra based syrup reduce the risk of
respiratory complications compared with no alternative treatment. Based on the findings from
the articles chosen, this researcher recommends S.nigra supplementation in supporting the
immune response when suffering from cold and flu symptoms. While more research is
necessary to validate these findings, enough research is available to support its use.
INTEGRATIVE REVIEW 11
References
Alvarez, C. A., Barriga, A., Albericio, F., Romero, M. S., & Guzman, F. (2018, March 27).
Chen, C., Zuckerman, D. M., Brantley, S., Sharpe, M., Childress, K., Hoiczyk, E., & Pendleton,
A. R. (2014). Sambucus nigra extracts inhibit infectious bronchitis virus at an early point
10-24
Shahsavandi, S., Ebrahimi, M. M., & Farahani, A. H. (2017). Interfering with lipid raft
https://www.ncbi.nlm.nih.gov/pubmed/29201101
Tiralongo, E., Wee, S. S., & Lea, R. A. (2016, February 8). Elderberry supplementation reduces
Volpe, A. D., Ricci, G., Ralli, M., Gambacorta, V., De Lucia, A., Minni, A., ... Di Stadio, A.
(2019). The effects of oral supplements with Sambucus nigra, zinc, tyndallized
otitis media with effusion in children: a randomized controlled trial. European Review for
doi.org/10.26355/eurrev_201907_18460
INTEGRATIVE REVIEW 12
Article Reference Alvarez, C.A., Barriga, A., Fernando, A., Romero, M. S.,
Guzman, F. (2018). Identification of peptide in flowers of
Sambucus-nigra with antimicrobial activity against
aquaculture pathogens. Molecules (23) 1033.
doi:10.3390/molecules23051033.
Framework
Findings/Discussion Findings/Results:
The SEM images of A. salmonicida treated with peptide
extract showed membrane damage and intracellular contents
were released in bacteria, in addition to membrane blebbing,
suggesting membrane disruption.
The SEM images suggests that peptides from S. nigra
flowers use a carpet mechanism to kill bacteria.
Discussion/Implication:
The presence of cysteine-rich peptides in flowers of S. nigra
exhibited antimicrobial activity again gram-negative
pathogens found in Chilean aquaculture.
This antimicrobial activity demonstrated a disruption in the
cellular membrane. Further studies are necessary to
determine the structure and activity of each peptide present
in the S. nigra flower.
Appraisal/Worth to This scientific experiment should be able to be repeated for
validity
practice Further research is necessary
This is a relevant article that can be used for the PICO
question
INTEGRATIVE REVIEW 14
Framework
Design/ Design:
Method/Philosophical The infections and titers were performed using Vero cells
Underpinnings After initial screening, the following S. Nigra extract
treatments were assessed for their ability to inhibit IBV either
alone or in combinations:
1. Exposing cells to extract prior to infection
2. Exposing cells to extract following infection
3. Exposing virus to extract prior to infection
4. Exposing both cells and virus to extract during infection
Sample/ The research protocol used for this study was approved by the
Health and Biosafety Committee at Emory University.
Setting/Ethical No human or animal subjects were used.
Considerations
appropriate
INTEGRATIVE REVIEW 15
Framework
appropriate
Framework
Relevant to PICO
INTEGRATIVE REVIEW 22
Conceptual/theoretical None
framework
Major Variables Studied 198 children children divided into four groups.
Group 1 (48 subjects) received 10mL of oral
(and if their definition), if supplements with immune-stimulating molecules for
three months (20 days consecutively, then 10 days of
appropriate
suspension-the therapeutic scheme was repeated three
times).
Group 2 (54 children) underwent treatment with 10
mL of OS for 90 consecutive days;
Group 3 (48 subjects) received 15mL of OS for 45
consecutive days